Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study
Laurent Meijer, Geneviève Héry-Arnaud, Cyril Leven, Emmanuel Nowak, Sophie Hillion, Yves Renaudineau, I. Durieu, R. Chiron, Anne Prévötat, Isabelle Fajac, D. Hubert, M. Murris‐Espin, S. Hüge, Isabelle Danner‐Boucher, Bruno Ravoninjatovo, Sylvie Leroy, Julie Macey, T. Urban, G. Rault, Dominique Mottier, Rozenn Le Berre
Topics & Concepts
MedicinePlaceboCystic fibrosisAdverse effectInternal medicineGastroenterologyPharmacokineticsMucositisPharmacologyChemotherapyPathologyAlternative medicineCystic Fibrosis Research AdvancesLung Cancer Treatments and MutationsAdvanced Breast Cancer Therapies